J.C., H.G. Heng, H.Y. Weng, et al. 2015. Effect of a limited iodine diet on iodine uptake by thyroid glands in hyperthyroid cats. J Vet Intern Med 29:1322–1326.605 Seguin, B., N.F. Leibman, V.S. Bregazzi, et al. 2001. Clinical outcome of dogs with grade‐II mast cell tumors treated with surgery alone: 55 cases (1996–1999). J Am Vet Med Assoc 218:1120–1123.
606 Seguin, B., D.E. McDonald, M.S. Kent, et al. 2005. Tolerance of cutaneous or mucosal flaps placed into a radiation therapy field in dogs. Vet Surg 34:214–222.
607 Seguin, B., M.D. O’Donnell, P.J. Walsh, et al. 2017. Long‐term outcome of dogs treated with ulnar rollover transposition for limb‐sparing of distal radial osteosarcoma: 27 limbs in 26 dogs. Vet Surg 46:1017–1024.
608 Seguin, B., P.J. Walsh, D.R. Mason, et al. 2003. Use of an ipsilateral vascularized ulnar transposition autograft for limb‐sparing surgery of the distal radius in dogs: An anatomic and clinical study. Vet Surg 32:69–79.
609 Seiler, R.J. 1979. Colorectal polyps of the dog: A clinicopathologic study of 17 cases. J Am Vet Med Assoc 174:72–75.
610 Selmic, L.E., J.H. Burton, D.H. Thamm, et al. 2014. Comparison of carboplatin and doxorubicin‐based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med 28:554–563.
611 Selting, K.A., B.E. Powers, L.J. Thompson, et al. 2005. Outcome of dogs with high‐grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996–2004). J Am Vet Med Assoc 227:1442–1448.
612 Seo, K.W., U.S. Choi, Y.C. Jung, et al. 2007. Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog. J Vet Med Sci 69:201–204.
613 Shirafuji, T., T. Oka, T. Sawada, et al. 2001. The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents. Surg Today 31:308–316.
614 Shiu, K.B., A.B. Flory, C.L. Anderson, et al. 2011. Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma. J Am Vet Med Assoc 238:472–479.
615 Sicotte, V., J. Benamou, L.C. Fifle, et al. 2012. Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma. J Am Vet Med Assoc 241:1639–1644.
616 Silver, M., A. Rusk, B. Phillips, et al. 2012. Evaluation of the oral antimitotic agent (Abt‐751) in dogs with lymphoma. J Vet Intern Med 26:349–354.
617 Simcock, J.O., S.S. Withers, C.Y. Prpich, et al. 2012. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006–2010). J Am Vet Med Assoc 241:608–614.
618 Simpson, A.M., L.L. Ludwig, S.J. Newman, et al. 2004. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 224:236–240.
619 Singh, A., S.E. Boston, and R. Poma. 2010. Thymoma‐associated exfoliative dermatitis with post‐thymectomy myasthenia gravis in a cat. Can Vet J 51:757–760.
620 Sivacolundhu, R.K., J.J. Runge, T.A. Donovan, et al. 2013. Ulnar osteosarcoma in dogs: 30 cases (1992–2008). J Am Vet Med Assoc 243:96–101.
621 Skorupski, K.A., C.A. Clifford, M.C. Paoloni, et al. 2007. CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med 21:121–126.
622 Skorupski, K.A., C.O. Rodriguez, E.L. Krick, et al. 2009. Long‐term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy. Vet Comp Oncol 7:139–144.
623 Skorupski, K.A., J.M. Uhl, A. Szivek, et al. 2016. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: A randomized, phase III trial. Vet Comp Oncol 14(1):81–87.
624 Slawienski, M.J., G.E. Mauldin, G.N. Mauldin, et al. 1997. Malignant colonic neoplasia in cats: 46 cases (1990–1996). J Am Vet Med Assoc 211:878–881.
625 Sleeckx, N., H. De Rooster, E.J. Veldhuis Kroeze, et al. 2011. Canine mammary tumours, an overview. Reprod Domest Anim 46:1112–1131.
626 Smith, J., M. Kiupel, J. Farrelly, et al. 2017. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone. Vet Comp Oncol 15:36–45.
627 Smith, J.D., E.A. Stone, and S.D. Gilson. 1995. Placement of a permanent cystostomy catheter to relieve urine outflow obstruction in dogs with transitional cell carcinoma. J Am Vet Med Assoc 206:496–499.
628 Smith, A.N., J.C. Wright, W.R. BrawnerJr., et al. 2001. Radiation therapy in the treatment of canine and feline thymomas: A retrospective study (1985–1999). J Am Anim Hosp Assoc 37:489–496.
629 Song, T., W. Wang, P. Liu, et al. 2009. Pharmacokinetic comparison between pelvic transarterial chemoembolization and transcatheter arterial chemotherapy in an animal model. Mol Med Rep 2:663–667.
630 Sorenmo, K.U., J.L. Baez, C.A. Clifford, et al. 2004a. Efficacy and toxicity of a dose‐intensified doxorubicin protocol in canine hemangiosarcoma. J Vet Intern Med 18:209–213.
631 Sorenmo, K., L. Duda, L. Barber, et al. 2000a. Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J Vet Intern Med 14:395–398.
632 Sorenmo, K.U., M.H. Goldschmidt, F.S. Shofer, et al. 2004b. Evaluation of cyclooxygenase‐1 and cyclooxygenase‐2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Vet Comp Oncol 2:13–23.
633 Sorenmo, K.U., K.A. Jeglum, and S.C. Helfand. 1993. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med 7:370–376.
634 Sorenmo, K.U., E. Krick, C.M. Coughlin, et al. 2011. CD40‐activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non‐Hodgkin's lymphoma. PLoS One 6:e24167.
635 Sorenmo, K., B. Overley, E. Krick, et al. 2010. Outcome and toxicity associated with a dose‐intensified, maintenance‐free CHOP‐based chemotherapy protocol in canine lymphoma: 130 cases. Vet Comp Oncol 8:196–208.
636 Sorenmo, K.U., M. Samluk, C.A. Clifford, et al. 2005. Efficacy and toxicity of intracavitary administration of pegylated liposomal encapsulated doxorubicin (Doxil) in dogs with haemangiosarcoma. Vet Comp Oncol 3(1):55–56.
637 Sorenmo, K.U., F.S. Shofer, and M.H. Goldschmidt. 2000b. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med 14:266–270.
638 Sorenmo, K.U., D.R. Worley, and M.H. Goldschmidt. 2013. 27 – Tumors of the mammary gland. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.
639 Spangler, W.L. and M.R. Culbertson. 1992. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985–1989). J Am Vet Med Assoc 200:829–834.
640 Spangler, W.L. and P.H. Kass. 1997. Pathologic factors affecting postsplenectomy survival in dogs. J Vet Intern Med 11:166–171.
641 Sparkes, A., S. Murphy, F. McConnell, et al. 2005. Palliative intracavitary carboplatin therapy in a cat with suspected pleural mesothelioma. J Feline Med Surg 7:313–316.
642 Spodnick,
